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Intensive care unit (ICU) capacity 
Trust in medical experts 
A B S T R A C T   
Background: Overcoming coronavirus disease (COVID-19) will likely require mass vaccination. With vaccination 
scepticism rising in many countries, assessing the willingness to vaccinate against COVID-19 is of crucial global 
health importance. 
Objective: The goal of this study was to examine how personal and family COVID-19 risk and ICU (intensive care 
unit) availability just before the pandemics influence the acceptance of future COVID-19 vaccines. 
Methods: A two-leg survey was carried out for comparing vaccination attitudes pre-and post-COVID-19. UK 
residents were surveyed in October 2019 about their vaccination attitudes, and again in a follow-up survey in 
April 2020, containing the previous questions and further ones related to COVID-19 exposure and COVID-19 
vaccine attitudes. The study combined survey results with local COVID-19 incidence and pre-COVID-19 mea-
sures of ICU capacity and occupancy. Regression analysis of the impact of individual and public health factors on 
attitudes towards COVID-19 vaccination was performed. 
Results: The October 2019 survey included a nationally representative sample of 1653 UK residents. All of them 
were invited for the follow-up survey in April 2020, and 1194 (72%) participated. The April 2020 sample 
remained nationally representative. Overall, 85% of respondents (and 55% of vaccine sceptics) would be willing 
to be vaccinated against COVID-19. Higher personal and family risk for COVID-19 was associated with stronger 
COVID-19 vaccination willingness, whereas low pre-COVID-19 ICU availability was associated with lower trust 
in medical experts and lower COVID-19 vaccine support. Further, general vaccination support has risen during 
the COVID-19 pandemic. 
Conclusion: Support for COVID-19 vaccination is high amongst all groups, even vaccine sceptics, boding well for 
future vaccination take-up rates. Vaccination willingness is correlated with health care availability during the 
COVID-19 crisis, suggesting a powerful synergy between health care system performance during crisis and the 
general population’s trust in the medical profession – as reflected in vaccination support.   
Introduction 
Since January 2020, SARS-Cov-2 has infected over 50 million people 
worlwide, leading to more than 3.2 million deaths. As of November 
2020, there was no effective treatment; only large-scale vaccination will 
allow a return to ‘normal life’. The novel threat posed by COVID-19 and 
need for mass vaccination comes at a time of growing vaccine hesitancy 
– a reluctance or refusal to vaccinate despite vaccine availability – in 
developed countries.1 For example, only 47% of French citizens, 67% of 
Germans, and 72% of Americans currently believe that vaccines are 
safe.2 Accordingly, vaccination rates have fallen in many rich countries 
in recent years, such as in the United Kingdom (UK), France and the 
Netherlands.3,4 Even before the COVID-19 crisis, the World Health Or-
ganization ranked vaccine hesitancy as one of the top ten global health 
threats.5 For all these reasons, the National Institutes of Health (NIH) 
recently expressed concern that vaccine scepticism could undermine 
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COVID immunization efforts.6 
Vaccine hesitancy creates a major risk of suboptimal health out-
comes for the general population7 and has several causes8,9: lack of 
confidence, complacency, constraints, calculation, and lack of collective 
responsibility. Growing vaccination fatigue and dropping vaccination 
rates have variously been attributed to low public trust in vaccines and 
health system, lack of perceived risks, wrong beliefs and misinforma-
tion, including the spread of fake news through social media, constraints 
on affordable and accessible vaccines, and insufficient governmental 
vaccine investments.5,10–14 Significant resistance to the measles vaccine 
can be traced back to a single scientific paper retracted in 2010.15 
Further, the limited risk of contracting vaccine-preventable diseases 
(VPDs) and perceived low severity of VPDs have arguably reduced 
vaccination rates prior to COVID-19.11 Also, “free-riding” is a distinct 
possibility, with citizens deliberately benefitting from the vaccination 
efforts of others while reducing their own, resulting in socially 
sub-optimal vaccination rates.7 
In general, few socio-economic variables predict vaccine scepticism. 
While education and higher income are associated in some countries 
with higher vaccination rates, in others they are correlated with vaccine 
hesitancy.16 Older respondents are generally less vaccine-hesitant, while 
the unemployed tend to be more skeptical.17 Individual vaccination 
choices are often strongly influenced by a person’s social network and 
prevailing local social norms.16 In a representative sample of UK resi-
dents, almost a third of respondents were vaccine-hesitant for at least 
half (5 out of 10) of the assessed questions.17 Lack of awareness of 
vaccines’ benefits and fear of side-effects were the main reasons for 
vaccine-scepticism. In particular, 79% of vaccine-hesitant respondents 
stated a lack of trust in immunization programs as the reason for 
hesitancy.12 
To date, few interventions have been successful in overcoming vac-
cine hesitancy. While information provision can have some effect (such 
as e.g. educational pamphlets or web-based decision aids), many in-
terventions yield neutral or counterproductive results.18 In particular, 
only half (5 out of 10) of the interventions using educational information 
to boost vaccination rates have led to a significant increase in vaccina-
tion intentions.13 Even in the case of successful interventions,19 a sub-
stantial share of anti-vaccine militants remains who are concerned about 
autism and bowel disease, despite being confronted with robust scien-
tific evidence. Proximity to actual disease outbreaks – as in the case of 
measles – appears to have no overall effect on attitudes towards 
vaccines.20 
The historic COVID-19 pandemic may affect attitudes towards 
vaccination for several reasons: First, COVID-19 involves higher per-
sonal stakes than many other diseases. In particular, some vaccine- 
preventable diseases are perceived as relatively mild and have a low 
probability of infection.11 In contrast, because COVID-19 is highly in-
fectious and has a relatively high case-mortality rate with no hope for 
herd immunity anytime soon, incentives for vaccination are greater. 
Second, suspension of social distancing measures and economic recov-
ery will require successful immunization of large portions of the global 
population against COVID-19.21 Third, the success of public health 
systems in dealing with the historic COVID-19 challenge may affect 
support for alternative (non-scientifically evaluated) approaches and 
methods. 
Methods 
Our study aims to assess attitudes towards COVID-19 vaccination 
and to examine how the COVID-19 crisis affects support for vaccination 
in general. The effect of socio-economic characteristics and public 
health parameters on these attitudes were also considered. Our data 
comes from two surveys and a number of publicly available sources. 
First, we surveyed a nationally representative sample of 1653 UK 
residents in October 2019 (pre-COVID-19) about their vaccination at-
titudes. The survey was administered by YouGov on the internet and 
incentivized participation with small lottery prizes. Respondents were 
sampled from a pool of individuals registered on the YouGov platform 
and willing to participate in surveys. For the sake of ensuring a repre-
sentative sample, they were selected with a quota sampling method, 
using stratification by age, gender and education (joint), social grade, 
political attention, 2017 vote and region (joint) and 2019 EU vote and 
region (joint). Quota targets were taken from the most recent official 
statistics (census and electoral data). Surveys are a powerful tool for 
predicting actual vaccination decisions.22 
This first survey mainly asked whether respondents would favor 
penalties for parents who refuse to vaccinate their children, in the form 
of fines, child benefit withdrawal, or bans from school. The same 1653 
UK residents were contacted again for a second survey in April 2020 at 
the peak of the COVID-19 pandemic. For these individuals, information 
on pre-COVID-19 (October 2019) values of vaccination attitudes and 
socio-economic characteristics (age, gender, education level, income 
class, political attitudes) as well as the respondent’s approximate loca-
tion (first four digits of the UK postcode) were available. In addition, the 
April 2020 follow-up survey asked a set of additional questions about 
the perceived risk of COVID-19 for respondents or their immediate 
family, attitudes towards COVID-19 vaccination, and a battery of 
questions on political views. The survey questions are listed in the 
Supplementary Material. 
We combined these survey results with a series of indicators of dis-
ease incidence and health care availability for the public health care 
system (NHS) in the area of residence. In particular, we used data from 
the Office of National Statistics23 on the number of deaths from 
COVID-19 occurring until 10th April 2020, four days before the start of 
the survey (14th April 2020) at the local authority level. The study has 
also examined how intensive care unit (ICU) capacities in late February 
2020 affected vaccination attitudes. The ICU availability could reflect 
deep-seated, long-run factors that simultaneously determine the allo-
cation of public healthcare infrastructure and vaccination attitudes, 
instead of capturing health care performance during the COVID-19 
crisis. To rule this out, we used past ICU availability (i.e. from late 
February 2020). 
We used Ordinary Least Squares (OLS) multivariate regressions to 
assess the relative importance of factors determining attitudes towards 
COVID-19 vaccination (specifications with probit estimators are shown 
in Tables S2 and S5). Our main dependent variable was an indicator 
variable taking value 1 if the respondent stated that he definitely or 
probably would not be vaccinated against COVID-19. The specification 
controlled for numerous potential confounders, including pre-COVID-19 
attitudes towards vaccines in general (the questions asked in October 
2019), the local COVID-19 incidence (COVID-19 deaths per 1000 peo-
ple), all individual socio-demographic characteristics available (gender, 
3 age categories, two social class indicators and 3 education level in-
dicators), as well as for local population characteristics (share of pop-
ulation above 65 years old and life expectancy at 65 years old for men 
and women separately) which were selected to control for potential 
vulnerability of different areas of England. Standard errors were clus-
tered at the level of the local authority to account for intra-cluster cor-
relation of errors. We reported results for the full sample and three 
subsamples which were labelled as “no vax,” “hesitants,” and “pro vac.” 
Respondents were assigned to one of these three categories based on 
their answers to a set of 8 questions. Each question presented a state-
ment about vaccines and asked the respondent to rate it on a 4-level 
scale: “definitely true,” “probably true,” “probably false” and “defi-
nitely false.” We generated an aggregate score based on these answers 
and used it to divide respondents into the three categories (See Section 
S.2 in the Supplementary Materials for additional details). 
All participants have given written consent for survey participation 
and results to be published. All the statistical analysis and data storing 
used anonymized data that did not allow to identify individual 
participants. 
The current study has been approved by the institutional ethics 
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review board of HEC Lausanne, University of Lausanne (assigned 
acronym: VACAT). This study has been recorded at ClinicalTrials.gov, 
with identifier NCT04352582. 
Results 
1653 (i.e. 93% of the respondents registered for participation and 
directed to the specific survey on vaccine attitudes) completed the 
questionnaire. 1194 (72%) of the initial participants responded to the 
second survey. This follow-up survey in April 2020 was also nationally 
representative (see Table 1). Average socio-demographic characteristics 
were very similar for the October 2019 and April 2020 samples and the 
average of the UK population as a whole. When studying if selection bias 
could be a concern, the non-response rates were not correlated with 
answers to the October 2019 vaccination questions (Table S1). 
In our nationally representative sample, 85% of respondents were 
either definitely or probably willing to become vaccinated against 
COVID-19 (see Fig. 1, left bar). Only 8% said that they would either 
probably or definitely not take the vaccine. Attitudes towards vaccina-
tion in general correlated with willingness to receive a potential COVID- 
19 vaccine. In the group of people generally favorable to vaccination (i. 
e. the ProVac group), 95% stated that they would like to be vaccinated. 
However, even among the most skeptical – who believed that vaccines 
cause autism and have few demonstrable benefits – 24% would “defi-
nitely” like to be vaccinated and another 31% would probably do so. 
Only 29% thought they would probably or definitely not do so. A similar 
pattern emerged for the question about making COVID-19 vaccination 
mandatory, with 36% of the most skeptical respondents favoring a legal 
obligation to be vaccinated (see Supplementary Fig. S2). 
We observed that lower availability of public health resources was 
associated with lower willingness to become vaccinated during the 
recent COVID-19 crisis (Fig. 2). In particular, in the April 2020 cross- 
section, lower availability of ICU units in an area and a higher occu-
pancy ratio of these ICUs were both associated with more limited sup-
port for COVID-19 vaccination, while late-February 2020 ICU capacity 
use was strongly correlated with COVID-19 mortality rates at the peak of 
the crisis (Fig. S4 and Table S4 in the Supplementary Material). 
In particular, the highest share of respondents unwilling to be 
vaccinated lived in areas where ICU units were near capacity by the end 
of February 2020, immediately before the COVID-19 crisis hit the UK 
(see Panel A of Fig. 2 which displays a simple binscatter of willingness to 
vaccinate against ICU occupancy in late February 2020; for expositional 
clarity, we averaged values of observations into equal-sized bins to 
produce this and the following graph). The effect was independent of 
pre-existing attitudes towards vaccination – both sceptics and vaccina-
tion supporters showed higher rates of support for COVID-19 -vaccina-
tion where England’s National Health Service had enough free ICU 
capacities. 
This positive association between ICU occupancy and vaccination 
scepticism also holds in a multivariate setting: Fig. 2, Panel B plots the 
regression coefficients for two specifications – a baseline adjusting for 
perceived risk, the other main explanatory variable (either ICU occu-
pancy or ICU per capita availability), plus an indicator variable for 
knowing someone with COVID-19, and one using a full set of covariates 
including age, socio-economic status, education, gender, marital status, 
and regional fixed effects. In both cases, the effect of ICU occupancy was 
highly significant. As the disaggregation by subgroup showed, the 
biggest effect was visible among vaccination hesitants – those with a 
somewhat ambivalent attitude towards vaccines. There was also a sig-
nificant but much smaller effect for the pro vaccination group. The no 
Table 1 
Characteristics of survey respondents and representativeness of samples.   
United Kingdom Survey respondents Difference 2019–2020 p-value 
2019 2020 
Totals 61′371′315  1′653 1′194    
North Easta 2′596′886 4% 5% 4% 0.55% 0.4781 
North Westa 7′052′177 11% 10% 10% 0.56% 0.6243 
Yorkshire and the Humbera 5′283′733 9% 9% 8% 0.72% 0.5001 
East Midlandsa 4′533′222 7% 9% 10% − 0.97% 0.3796 
West Midlandsa 5′601′847 9% 8% 8% 0.34% 0.7396 
East of Englanda 5′846′965 10% 12% 12% − 0.74% 0.5481 
Londona 8′173′941 13% 11% 10% 0.60% 0.6067 
South Easta 8′634′750 14% 12% 13% − 0.69% 0.5878 
South Westa 5′288′935 9% 10% 11% − 0.81% 0.4878 
Walesa 3′063′456 5% 6% 5% 0.40% 0.6427 
Scotlanda 5′295′403 9% 9% 9% 0.04% 0.9715  
Mena 30′140′820 49% 44% 46% − 1.64% 0.3849 
Womena 31′230′495 51% 56% 54% 1.64% 0.3849  
18-34 y.o.a 13′961′474 29% 25% 20% 5.00% 0.0016 
35-54 y.o.a 17′054′980 35% 33% 34% − 0.59% 0.7411 
55+ y.o.a 17′341′897 36% 42% 47% − 4.41% 0.0194  
High social classb,c 21′381′588 57% 59% 59% 0.01% 0.9945 
Low social classb,c 16′389′669 43% 41% 41% − 0.01% 0.9945  
Education: entry levelb 14′701′183 31% 29% 30% − 0.82% 0.6441 
Education: some qualificationb 9′548′605 27% 30% 31% − 0.59% 0.7419 
Education: universityb 11′059′503 42% 41% 40% 1.41% 0.4619 
Notes: Col. 1 and 2 report totals and shares for the United Kingdom. Col. 3 reports characteristics of respondents to the 6–7 October 2019 survey. Col. 4 the char-
acteristics of respondents on 9–16 April 2020. Every respondent in April 2020 completed the previous survey. Col. 5 reports the difference between col. 3 and col. 4. 
Col. 6 reports the p-value of a test that this number is different from 0, showing absence of differential attrition for all but 1 variable (age). 
a 2011 Population Census. 
b 2014 Integrated Household Survey; total numbers represent sum of weights. 
c Social class is National Statistics Socio-economic Classification for the United kingdom and NRS social grade for the samples. High social class is 1–4 in NSSEC and 
A-C1 in NRS. 
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vaccination group on average appeared to react to ICU occupancy, but 
estimates were not significantly different from zero. 
A similar pattern was apparent for another indicator of public health 
system capacity – ICU beds per 1000 inhabitants (Fig. 2, Panels C and D). 
Where the NHS had ample hospital beds available before the COVID-19 
crisis hit, vaccination unwillingness in general was much lower. The 
lower the number of ICU units in an area, the more people indicated that 
they would be unwilling to be vaccinated. The effect was significant at 
the 90% level without covariates and 95% level with covariates. The 
average coefficient was largest for vaccination sceptics, but with large 
standard errors. Hesitants appeared less influenced by ICU provision. 
Neither ICU provision per capita nor occupancy rates in October 
2019 predicted attitudes towards COVID-19 vaccination, nor did they 
have predictive power for trust in medical experts and scientists during 
the COVID-19 crisis (see Table S3) – it was only health care availability 
during the coronavirus outbreak (i.e. ICU availability in February 2020) 
that mattered for attitudes. 
The ICU availability immediately prior to the COVID outbreak was 
also a significant predictor of trust in science and the medical profession: 
where the NHS ran out of ICU capacity during the COVID-19 crisis, trust 
in science and medical experts was markedly lower (see Table 2 with 
OLS estimates and Table S5 with Probit estimates). In areas where 90% 
or more of ICU beds were occupied by late February 2020, only 35% of 
respondents had a lot of confidence, compared with 42% in the sample 
overall. The same pattern was true – in reverse – for ICU provision per 
capita, with greater numbers of ICU units in the nearest hospital pre-
dicting more trust in health experts and scientists. 
Personal risk was also an important determinant of attitudes: survey 
respondents who thought that COVID-19 posed a clear risk to them-
selves or family members were much more likely to be willing to be 
vaccinated (see Fig. 2, Panels E and F). The share of respondents un-
willing to be vaccinated in the at-risk group was a mere 4%, compared 
with 10% in the no-risk group. The difference was largest among 
vaccination sceptics. Hesitants and pro vaccination respondents also 
reacted to personal risk, but the effects were smaller; for the hesitants, 
the effect became insignificant when adjusting for the full set of 
covariates. 
Finally, we examined whether the COVID-19 crisis changed vacci-
nation attitudes at the individual level over time. As individuals were 
asked the same questions about support for punishing vaccination 
evaders twice – in October 2019 and April 2020 – we could directly 
examine this issue. Of the three measures – keeping non-vaccinated 
children out of school, cutting parents’ benefits, and fining the parents 
if a child was not vaccinated – only one measure (fining) saw a major 
increase in support during the COVID-19 crisis (Fig. S3). No additional 
support for withholding attendance or cutting benefits was forthcoming 
in the sample. At the same time, 1 out of 10 respondents who stated that 
parents who refused to vaccinate should not be fined changed their mind 
by April 2020, a mere 7 months later. The rise in support for fines was 
mainly driven by those with pro-vaccination attitudes – and to a lesser 
extent, the vaccination hesitants. Respondents with anti-vaccine beliefs 
did not change their support for penalties, despite the severity of the 
COVID-19 crisis and their frequent willingness to become vaccinated 
against COVID-19. 
Discussion 
Can vaccination stop COVID-19? Given the new virus’ infectious-
ness, for vaccination to succeed, take-up rates will have to be high. High 
support cannot be taken for granted, given the general rise of vaccine 
hesitancy in recent years. 
Our nationally representative survey of UK respondents showed 
substantial support for vaccination across all socio-economic groups, 
and even among vaccination sceptics. Some of this reflects perceived 
personal risk: Having a close family member at risk sharply increased 
support for vaccination (Fig. 2). Even respondents who believed that 
vaccines can cause autism, have other severe side-effects, generate few 
benefits, and are mainly prescribed because of financial interests of the 
pharmaceutical industry, were overwhelmingly willing to become 
vaccinated against COVID-19 in April 2020 (Fig. 1). This implies that 
vaccine hesitancy is unlikely to impede herd immunity against COVID- 
19 through vaccination. 
Areas with more limited ICU capacity experienced sharply higher 
case fatality rates. ICU availability was a major concern among the 
public during the pandemic’s peak, in March and April 2020. We found 
that in areas where ICU availability was limited for exogenous reasons, 
vaccination support is markedly lower – and so is trust in medical ex-
perts and scientists. 
In general, vaccination can substitute for health interventions post- 
infection – higher immunization rates reduce the need for post- 
infection treatment. Hence, vaccination willingness should in principle 
be inversely related to the availability of health care support. In contrast, 
Fig. 1. COVID-19 vaccine acceptance and general 
vaccine attitudes. Notes: The figure shows responses 
to the question: “If a vaccine against COVID-19 
became available for everyone tomorrow, do you 
think you would or would not get vaccinated?” The 
bar on the left reports the breakdown for all re-
spondents of the April 2020 survey (N = 1194). The 
other 3 columns report the breakdown for three cat-
egories of respondents: “no vax” (N = 148), “hesi-
tants” (N = 431) and “pro vac” (N = 615). We assign 
respondents to one of these categories using ther an-
swers to the question on general vaccination atti-
tudes. See Section S.2 in the Supplementary Materials 
for details on the construction of these categories.   
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Fig. 2. ICU availability, perceived risk and unwillingness to get vaccinated against COVID-19. 
Notes: Resistance to vaccinate against COVID-19 is from the question: “If a vaccine against COVID-19 became available for everyone tomorrow, do you think you 
would or would not get vaccinated?” Respondents who would not vaccinate “definitely” and “probably” are coded as resistant. Panel A: unconditional binscatter of 
February 2020 ICU beds occupancy rate (x-axis) and resistance to COVID-19 vaccine (y-axis). From the full sample of respondents living in England we create 20 bins 
of roughly equal sample size; the last 2 bins have no variation in occupancy rate (100%) and are combined into a single data point. Panel C: unconditional binscatter 
of February 2020 ICU beds per 1000 people (x-axis) and resistance to COVID-19 vaccine (y-axis). From the full sample of respondents living in England we create 20 
bins of roughly equal sample size; some 30% of respondents live in a local authority without a NHS Trust: these bins are combined into a single data point. Panel E: 
share of respondents showing resistance to COVID-19 vaccine among those who state that COVID-19 does not poses a major risk to anyone in the household (left bar) 
and those who state that it does (right bar). The whiskers show the standard errors of the estimates. Panel B, D and F: OLS estimates and 95% confidence intervals 
from. 
COVID-19 Vax Resistancei = β0 + β1 ORi + β2 ICUi + β3 CoV19 Riski + βX Xi + ui 
Where COVID-19 Vax Resistance = 1 if respondent states that he would “definitely” or “probably” not vaccinate against COVID-19, and the other variables are defined 
in the footnote of Table 2. Panel B: estimates of β1. Panel D: estimates of β2. Panel F: estimates of β3. The specification with baseline covariates includes an indicator 
for whether the respondent knows someone infected with COVID-19. The specification with all covariates includes all explanatory variables in col. 4 of Table 2. “Full 
sample” includes all respondents living in England. The other three samples report estimates from three regressions estimated on the three samples: “no vax,” 
“hesitants,” and “pro vac.” Respondents are assigned to one of these categories using their answers to a question on general vaccination attitudes. See Section S.2 in 
the Supplementary Materials for details on the construction of these categories. Standard errors are clustered at the level of the local authority (269 clusters). 
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we find lower availability of public health resources to be associated 
with sharply lower willingness to become vaccinated during the recent 
COVID-19 crisis. As discussed above, in the April 2020 cross-section, 
lower availability of ICUs in an area and a higher occupancy ratio 
were both associated with more limited support for COVID-19 
vaccination. 
We used the occupancy rate in the nearest NHS hospital immediately 
before the crisis (late February 2020) as an explanatory variable,24 for 
three reasons. First, it is an important predictor of mortality rates: As 
discussed above, late February ICU capacity use was strongly correlated 
with COVID-19 mortality rates at the peak of the crisis. Second, late 
February ICU occupancy was excludable from the severity of the 
COVID-19 shock, almost no hospitalizations had occurred by then. Late 
February occupancy is therefore a plausible shifter of hospital capacity, 
reflecting the seriousness of other demands on the local health system. 
Third, ICU capacity was a major concern among the public during the 
COVID-19 crisis, as evidenced by Google search term frequency: Fig. S1 
in the Appendix shows how search frequency on Google peaked in late 
March/early April – the time of our follow-up survey. 
Our results underline the importance of trust and confidence in 
mainstream medicine as pre-condition for positive attitudes towards 
vaccination, as previously reported.12 It also highlights the risk of a vi-
cious circle, where negative attitudes towards vaccination lead to lower 
vaccination rates, greater numbers of severely ill patients in times of 
crisis, more pressure on ICUs, and in turn, less trust in the medical 
profession and science in general. This finding in particular highlights an 
important synergy between public health system performance and the 
public’s support for public health measures like large-scale vaccination. 
In conclusion, our results suggest that the availability of sufficient 
ICU places can contribute to building trust in medical experts and boosts 
the willingness to become vaccinated against COVID-19. 
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confidence: development of a measure assessing the 5C psychological antecedents 
of vaccination. PloS One. 2018;13(12):e0208601. 
[9] Oduwole EO, Pienaar ED, Mahomed H, Wiysonge CS. Current tools available for 
investigating vaccine hesitancy: a scoping review protocol. BMJ Open. 2019;9 
(e033245). 
10 Blendon RJ, DesRoches CM, Benson JM, Herrmann MJ, Taylor-Clark K, Weldon KJ. 
The public and the smallpox threat. N Engl J Med. 2003;348:426–432. 
11 Karafillakis E, Larson HJ, others. The benefit of the doubt or doubts over benefits? A 
systematic literature review of perceived risks of vaccines in European populations. 
Vaccine. 2017;35:4840–4850. 
12 Larson HJ, Schulz WS, Tucker JD, Smith DM. Measuring vaccine confidence: 
introducing a global vaccine confidence index. PLoS Curr. 2015;7. 
13 Sadaf A, Richards JL, Glanz J, Salmon DA, Omer SB. A systematic review of 
interventions for reducing parental vaccine refusal and vaccine hesitancy. Vaccine. 
2013;31:4293–4304. 
14 Shapiro GK, Tatar O, Dube E, et al. The vaccine hesitancy scale: psychometric 
properties and validation. Vaccine. 2018;36:660–667. 
15 Wilder-Smith AB, Qureshi K. Resurgence of measles in europe: a systematic review 
on parental attitudes and beliefs of measles vaccine. J Epidemiol Glob Health. 2020; 
10:46–58. 
Table 2 
ICU beds occupancy rate and trust in health experts and scientists.   
Trust in health experts 
1 2 3 4 
Closest ICU: occupancy 
rate (Feb 2020) 
− 0.221** − 0.207** − 0.227** − 0.230** 
[0.0931] [0.0922] [0.087] [0.089] 




0.250 0.158 0.207 
[0.195] [0.203] [0.224] 
COVID-19 poses major 
risk 
0.017 0.022 0.054 0.053 
[0.033] [0.033] [0.033] [0.033] 
Knows someone with 
COVID-19 
0.055 0.049 0.027 0.027 
[0.037] [0.037] [0.037] [0.037] 
COVID-19 deaths per 
1000 people 
− 0.114 − 0.146 − 0.199 − 0.180 
[0.150] [0.134] [0.132] [0.126] 
Oct 2019 vaccination 
attitudes 
No Yes Yes Yes 
Demographic controls No No Yes Yes 
Local Authority 
characteristics 
No No No Yes 
R2 0.011 0.032 0.071 0.072 
Mean dep var 0.418 0.418 0.418 0.418 
Observations 1017 1017 1017 1017 
Notes: The table reports OLS estimates of the following regression. 
Trusti = β0 + β1 ORi + β2 ICUi + β3 COVID-19 Riski + β4 COVID-19 Exposure+ β5 
COVID-19 Deathsi + βX Xi + ui 
Where Trust is an indicator variable = 1 if respondent reports “a great deal of 
trust” in health experts and scientists, OR is the occupancy rate of ICU beds in the 
NHS trust that is closest to the zip code where the respondent lives, ICU is the 
number of ICU beds per 1000 people in the local authority where the respondent 
lives, COVID-19 Risk is an indicator variable = 1 if the respondent states that 
COVID-19 poses a major risk to either himself or someone living in his house-
hold, COVID-19 Exposure is an indicator variable = 1 if respondent knows 
someone infected with COVID-19 and COVID-19 Deaths is the number of COVID- 
19 deaths per 1000 people in the local authority as of 10 April 2020. Col. 1 
includes only these covariates. Col. 2 includes the answers to 3 questions on 
vaccination attitudes asked in October 2019: “should unvaccinated kids be 
allowed to attend school?” “should parents who choose not to vaccinate their 
kids be banned from childcare benefits?” and “should parents who choose not to 
vaccinate their kids be fined?“. For each of these questions, we create an indi-
cator variable = 1 if the respondent stated that he would punish parents who 
choose not to vaccinate their kids, showing support for measures promoting 
vaccination. Col. 3 adds a gender indicator variable, 3 age groups dummies 
(18–34; 35–54 and 55+), an indicator variable for high social status (level A-C1 
in the NRS classification) and 3 education dummies (low, mid, and high level). 
Col. 4 adds characteristics of the local authority where the individual lives: the 
share of people above 65 years old and the life expectancy at 65 for both men 
and women. The sample includes all respondents re-contacted in April 2020 and 
living in England. Standard errors are clustered at the level of the local authority 
(269 clusters). 
G. Blanchard-Rohner et al.                                                                                                                                                                                                                   
Journal of Virus Eradication 7 (2021) 100044
7
16 Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine 
hesitancy around vaccines and vaccination from a global perspective: a systematic 
review of published literature, 2007–2012. Vaccine. 2014;32:2150–2159. 
17 Luyten J, Bruyneel L, van Hoek AJ. Assessing vaccine hesitancy in the UK population 
using a generalized vaccine hesitancy survey instrument. Vaccine. 2019;37: 
2494–2501. 
18 Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion: a 
randomized trial. Pediatrics. 2014;133:e835–e842. 
19 Wallace C, Leask J, Trevena LJ. Effects of a web based decision aid on parental 
attitudes to MMR vaccination: a before and after study. BMJ. 2006;332:146–149. 
[20] Justwan F, Baumgaertner B, Carlisle JE, Carson E, Kizer J. The effect of trust and 
proximity on vaccine propensity. PloS One. 2019;14(8):e0220658. 
21 Bonardi J-P, Bris A, Brülhart M, et al. The case for reopening economies by sectors. 
Harv Bus Rev; 2020 (available at https://hbr.org/2020/05/the-case-for-reopening-e 
conomies-by-sector. 
22 Opel DJ, Taylor JA, Zhou C, Catz S, Myaing M, Mangione-Smith R. The relationship 
between parent attitudes about childhood vaccines survey scores and future child 
immunization status: a validation study. JAMA Pediatr. 2013;167:1065–1071. 
23 Office of National Statistics. Deaths Registrations; 2020 (available at https://www.ons 
.gov.uk/peoplepopulationandcommunity/healthandsocialcare/causesofdeath/ 
datasets/deathregistrationsandoccurrencesbylocalauthorityandhealthboard/2020. 
24 NHS. Critical Care Bed Capacity; 2020 (available at https://www.england.nhs.uk/sta 
tistics/statistical-work-areas/critical-care-capacity/critical-care-bed-capacity-and-ur 
gent-operations-cancelled-2019-20-data/. 
G. Blanchard-Rohner et al.                                                                                                                                                                                                                   
